BLUE BIRD CORP (BLBD)
US0953061068 - Common Stock
We assign a fundamental rating of 6 out of 10 to BLBD. BLBD was compared to 131 industry peers in the Machinery industry. Both the profitability and the financial health of BLBD get a neutral evaluation. Nothing too spectacular is happening here. BLBD scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings would make BLBD suitable for value investing!
1. Profitability
1.1 Basic Checks
BLBD had positive earnings in the past year.
BLBD had a positive operating cash flow in the past year.
In multiple years BLBD reported negative net income over the last 5 years.
In multiple years BLBD reported negative operating cash flow during the last 5 years.
1.2 Ratios
BLBD has a Return On Assets of 21.26%. This is amongst the best in the industry. BLBD outperforms 99.21% of its industry peers.
The Return On Equity of BLBD (72.48%) is better than 98.43% of its industry peers.
With an excellent Return On Invested Capital value of 34.50%, BLBD belongs to the best of the industry, outperforming 99.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 21.26% | ||
| ROE | 72.48% | ||
| ROIC | 34.5% |
ROA(3y)-2.3%
ROA(5y)0.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BLBD's Profit Margin of 7.65% is fine compared to the rest of the industry. BLBD outperforms 62.20% of its industry peers.
In the last couple of years the Profit Margin of BLBD has declined.
BLBD has a Operating Margin (10.99%) which is in line with its industry peers.
BLBD's Operating Margin has improved in the last couple of years.
The Gross Margin of BLBD (18.97%) is worse than 74.02% of its industry peers.
In the last couple of years the Gross Margin of BLBD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.99% | ||
| PM (TTM) | 7.65% | ||
| GM | 18.97% |
OM growth 3Y22.15%
OM growth 5Y5.9%
PM growth 3Y14.85%
PM growth 5Y-5.7%
GM growth 3Y3.86%
GM growth 5Y0.59%
2. Health
2.1 Basic Checks
BLBD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for BLBD has been increased compared to 1 year ago.
The number of shares outstanding for BLBD has been increased compared to 5 years ago.
Compared to 1 year ago, BLBD has an improved debt to assets ratio.
2.2 Solvency
BLBD has an Altman-Z score of 6.41. This indicates that BLBD is financially healthy and has little risk of bankruptcy at the moment.
BLBD has a Altman-Z score of 6.41. This is amongst the best in the industry. BLBD outperforms 81.89% of its industry peers.
The Debt to FCF ratio of BLBD is 1.23, which is an excellent value as it means it would take BLBD, only 1.23 years of fcf income to pay off all of its debts.
BLBD has a Debt to FCF ratio of 1.23. This is amongst the best in the industry. BLBD outperforms 88.98% of its industry peers.
BLBD has a Debt/Equity ratio of 0.66. This is a neutral value indicating BLBD is somewhat dependend on debt financing.
The Debt to Equity ratio of BLBD (0.66) is worse than 69.29% of its industry peers.
Although BLBD does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 1.23 | ||
| Altman-Z | 6.41 |
ROIC/WACC3.74
WACC9.23%
2.3 Liquidity
A Current Ratio of 1.40 indicates that BLBD should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.40, BLBD is doing worse than 78.74% of the companies in the same industry.
BLBD has a Quick Ratio of 1.40. This is a bad value and indicates that BLBD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.66, BLBD is doing worse than 87.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1448.00% over the past year.
Measured over the past years, BLBD shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.41% on average per year.
The Revenue has grown by 19.53% in the past year. This is quite good.
The Revenue has been growing slightly by 2.02% on average over the past years.
EPS 1Y (TTM)1448%
EPS 3Y9.28%
EPS 5Y-8.41%
EPS Q2Q%106.82%
Revenue 1Y (TTM)19.53%
Revenue growth 3Y8.81%
Revenue growth 5Y2.02%
Sales Q2Q%13.28%
3.2 Future
BLBD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.39% yearly.
Based on estimates for the next years, BLBD will show a quite strong growth in Revenue. The Revenue will grow by 13.23% on average per year.
EPS Next Y219.78%
EPS Next 2Y87.52%
EPS Next 3Y60.39%
EPS Next 5YN/A
Revenue Next Year18.26%
Revenue Next 2Y14.11%
Revenue Next 3Y11.85%
Revenue Next 5Y13.23%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.06 indicates a correct valuation of BLBD.
Compared to the rest of the industry, the Price/Earnings ratio of BLBD indicates a rather cheap valuation: BLBD is cheaper than 86.61% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.96. BLBD is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 10.80 indicates a reasonable valuation of BLBD.
92.13% of the companies in the same industry are more expensive than BLBD, based on the Price/Forward Earnings ratio.
BLBD is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.06 | ||
| Fwd PE | 10.8 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BLBD is valued cheaper than 84.25% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BLBD is valued cheaply inside the industry as 83.46% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.59 | ||
| EV/EBITDA | 8.28 |
4.3 Compensation for Growth
BLBD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BLBD's earnings are expected to grow with 60.39% in the coming years.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y87.52%
EPS Next 3Y60.39%
5. Dividend
5.1 Amount
No dividends for BLBD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BLUE BIRD CORP
NASDAQ:BLBD (11/22/2024, 9:32:59 AM)
40.65
+0.57 (+1.42%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.32B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.06 | ||
| Fwd PE | 10.8 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.05
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 21.26% | ||
| ROE | 72.48% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 10.99% | ||
| PM (TTM) | 7.65% | ||
| GM | 18.97% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.78
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)1448%
EPS 3Y9.28%
EPS 5Y
EPS Q2Q%
EPS Next Y219.78%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)19.53%
Revenue growth 3Y8.81%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y